Symptom Burden in Chronic Myeloid Leukemia (CML)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
- Status
- TERMINATED
- Phase
- PHASE1
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
- Status
- TERMINATED
- Phase
- PHASE1
Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06
- Status
- COMPLETED
- Phase
- N/A
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A